메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Kensuke Sakurai (Hokkaido University Hospital) Shigeru Furukawa (Inflammatory Bowel Disease Center Sapporo Higashi Tokushukai Hospital) Takehiko Katsurada (Department of Gastroenterology and Hepatology Hokkaido University Hospital) Shinsuke Otagiri (Department of Gastroenterology and Hepatology Hokkaido University Hospital) Kana Yamanashi (Department of Gastroenterology and Hepatology Sapporo Hokushin Hospital) Kazunori Nagashima (Department of Gastroenterology and Hepatology Hokkaido University Hospital) Reizo Onishi (Department of Gastroenterology and Hepatology Hokkaido University Hospital) Keiji Yagisawa (Inflammatory Bowel Disease Center Sapporo Higashi Tokushukai Hospital) Haruto Nishimura (Inflammatory Bowel Disease Center Sapporo Higashi Tokushukai Hospital) Takahiro Ito (Inflammatory Bowel Disease Center Sapporo Higashi Tokushukai Hospital) Atsuo Maemoto (Sapporo Higashi Tokushukai Hospital) Naoya Sakamoto (Hokkaido University Hospital)
저널정보
대한장연구학회 Intestinal research Intestinal research Vol.20 No.1
발행연도
2022.1
수록면
78 - 89 (12page)
DOI
10.5217/ir.2020.00124

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background/Aims: Inflammatory bowel disease (IBD) patients frequently have zinc deficiency. IBD patients with zinc deficiency have higher risks of IBD-related hospitalization, complications, and requiring surgery. This study aimed to examine the effectiveness of zinc acetate hydrate (ZAH; Nobelzin) in IBD patients with zinc deficiency.Methods: IBD patients with zinc deficiency who received ZAH from March 2017 to April 2020 were registered in this two-center, retrospective, observational study. Changes in serum zinc levels and disease activity (Crohn’s Disease Activity Index [CDAI]) before and after ZAH administration were analyzed.Results: Fifty-one patients with Crohn’s disease (CD, n = 40) or ulcerative colitis (UC, n = 11) were registered. Median serum zinc level and median CDAI scores significantly improved (55.5?91.0 μg/dL, P< 0.001; 171.5?129, P< 0.001, respectively) in CD patients 4 weeks after starting ZAH administration. Similarly, median serum zinc levels and CDAI scores significantly improved (57.0?81.0 μg/dL, P< 0.001; 177?148, P= 0.012, respectively) 20 weeks after starting ZAH administration. Similar investigations were conducted in groups where no treatment change, other than ZAH administration, was implemented; significant improvements were observed in both serum zinc level and CDAI scores. Median serum zinc levels in UC patients 4 weeks after starting ZAH administration significantly improved from 63.0 to 94.0 μg/dL (P= 0.002), but no significant changes in disease activity were observed. One patient experienced side effects of abdominal discomfort and nausea.Conclusions: ZAH administration is effective in improving zinc deficiency and may contribute to improving disease activity in IBD.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0